Chas McKhann - 15 Apr 2026 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Reporting relationship: Director
Issuer ticker: COCH
Reported as of: 15 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Apr 2026, 16:32:04 UTC
Prior SEC filing: 16 Mar 2026
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Nick as Attorney-in-Fact for Chas McKhann pursuant to Power of Attorney previously filed.

Key filing fact

Chas McKhann filed Form 4 for Envoy Medical, Inc. (COCH) on 17 Apr 2026.

Key facts

This page summarizes Chas McKhann's Form 4 filing for Envoy Medical, Inc. (COCH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Apr 2026, 16:32.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001631746 Primary reporting owner

Relationship: Director
Address: 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE
Signature: /s/ Andrew Nick as Attorney-in-Fact for Chas McKhann pursuant to Power of Attorney previously filed.
Signature date: 17 Apr 2026

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

COCH transaction Derivative

Award

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Beginning on 5/15/2026, options to purchase Class A Common Stock will vest pro rata on the 15th of each month for 36 consecutive months.